-
EP4330379
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4330379
| EP4330379 - VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.02.2024 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 04.11.2022 | ||
| Former | unknown Status updated on 26.05.2022 | Most recent event Tooltip | 27.06.2024 | Change: Validation states | published on 31.07.2024 [2024/31] | 27.06.2024 | Change - extension states | published on 31.07.2024 [2024/31] | Applicant(s) | For all designated states Baylor College of Medicine One Baylor Plaza Houston, TX 77030 / US | [2024/10] | Inventor(s) | 01 /
QUACH, David H. Houston, TX 77030 / US | 02 /
ROONEY, Cliona M. Houston, TX 77030 / US | 03 /
RAMOS, Carlos A. Houston, TX 77030 / US | [2024/10] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2024/10] | Application number, filing date | 22723955.5 | 27.04.2022 | [2024/10] | WO2022US71950 | Priority number, date | US202163201384P | 27.04.2021 Original published format: US 202163201384 P | [2024/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022232797 | Date: | 03.11.2022 | Language: | EN | [2022/44] | Type: | A2 Application without search report | No.: | EP4330379 | Date: | 06.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.11.2022 takes the place of the publication of the European patent application. | [2024/10] | Search report(s) | International search report - published on: | EP | 15.12.2022 | Classification | IPC: | C12N5/0783, A61K35/17, A61K39/245, C07K14/05, A61P35/02 | [2024/10] | CPC: |
C12N5/0636 (EP,US);
A61K2239/26 (EP,US);
A61K2239/28 (EP,US);
A61K2239/29 (EP,US);
A61K2239/31 (EP,US);
A61K2239/38 (EP,US);
A61K2239/48 (EP,US);
A61K39/4611 (EP,US);
A61K39/4631 (EP,US);
A61K39/464412 (EP,US);
A61K39/464417 (EP,US);
A61K39/464838 (EP,US);
A61P35/02 (EP);
C07K14/005 (EP);
C12N2501/2302 (EP);
C12N2501/2307 (EP);
C12N2501/2315 (EP);
C12N2501/51 (EP);
C12N2501/515 (EP);
C12N2501/998 (EP);
C12N2506/11 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/10] | Title | German: | CHIMÄRE ANTIGENREZEPTOREN EXPRIMIERENDE VIRUSSPEZIFISCHE IMMUNZELLEN | [2024/10] | English: | VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS | [2024/10] | French: | CELLULES IMMUNITAIRES SPÉCIFIQUES À UN VIRUS EXPRIMANT DES RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES | [2024/10] | Entry into regional phase | 08.11.2023 | National basic fee paid | 08.11.2023 | Designation fee(s) paid | 08.11.2023 | Examination fee paid | Examination procedure | 08.11.2023 | Examination requested [2024/10] | 08.11.2023 | Date on which the examining division has become responsible | 23.05.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 08.11.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2019194619 (ROONEY CLIONA M [US], et al); | [Y]WO2020047452 (NOVARTIS AG [CH], et al); | [XY]US10772914 (ROONEY CLIONA M [US], et al); | by applicant | WO03059282 | WO2004010957 | WO2005001038 | US2005009769 | WO2006089232 | WO2007044616 | US2007166309 | WO2007084672 | US2007258987 | WO2011041093 | WO2012031744 | WO2013088114 | WO2015028444 | WO2016008973 | WO2017202478 | WO2018038945 | WO2018052947 | US2018250379 | WO2020068764 | WO2020214479 |